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INTRODUCTION
Preeclampsia is a pregnancy specific disorder which constitutes hypertension after 20 weeks of 
gestation and proteinuria. It is a multisystem disorders of unknown etiology. 
It is one of the commonest complications of pregnancy and is a major cause of maternal and foetal 
mortality and morbidity. In developing countries it ranks second to anaemia as a cause of maternal 
mortality and morbidity, complicating 7-10% of all pregnancies. Cardiac failure with pulmonary edema 
may occur in hypertensive patients with normal heart. It is emphasised that pregnant women 
particularly if pre-eclamptic develop pulmonary edema more often than non-pregnant women. Further 
preeclampsia is a recognised predisposing factor for peripartum cardiomyopathy and future 
cardiovascular disease.
Pregnancy is characterised by a number of important hemodynamic changes. Blood volume increases 
by about 50%. The red cell mass increases by about 40%. The resting pulse rate increases by about 10 
to 15 beats per minute. Cardiac output increases beginning in early pregnancy around 5th week and 
continues to increase and reaches its peak between the middle of 2nd and 3rd trimesters and remains 
elevated during the remainder of pregnancy. Systemic arterial pressure begins to fall during the first 
trimester, reaches a nadir in midpregnancy and returns to pre-gestational level before term. The pulse 
pressure widens as the fall of diastolic pressure is greater than the fall of systolic pressure. The 
reduction in blood pressure results from a decline in systemic vascular resistance that occurs during 
pregnancy. These changes are largely physiological in normal pregnancies. But these changes are 
critical in patients with preeclampsia. Many studies have addressed the issues in relation to cardiac 
output, systemic vascular resistance, left ventricular stroke volume and pulmonary capillary wedge 
pressure.
It is also been speculated that associated subclinical left ventricular dysfunction may contribute to 
cardiac mortality and morbidity. There are only few data available regarding left ventricular function in 
pregnancy. So this prospective study on left ventricular systolic and diastolic function by 
echocardiography was undertaken in normal and preeclamrptic pregnancies. 
REVIEW OF LITERATURE
historical prospective
Preeclampsia and Eclampsia is still shrouded in a cloud of mystery. Zweifel called it a disease of 
theories. Bernard wrote that Eclampsia was mentioned in the ancient Egyptian, Chinese, Indian and 
Greek literature. Probably the oldest reference is in the Advaitha Veda 200 BC.
classification of hypertensive disorders of pregnancy
Hypertensive disorders of pregnancy are classified in to five types by the working group of National 
High Blood Pressure Education Program (NHBPEP) (2000).
gestational hypertension
Blood Pressure (B.P) > 140/90 for first time during pregnancy without proteinuria.
B.P returns to normal < 12 weeks postpartum final diagnosis made only postpartum and may have other 
signs and symptoms of preeclampsia for example epigastric discomfort or thrombocytopenia.
PreEclampsia
B.P > 140/90mm Hg after 20 weeks of gestation Pronteinuria > 300 mg/24 hours or > 1 + dipstick.
INCREASED CERTAINTY OF PREECLAMPSIA
B.P > 160/110 mmHg
Proteinuria 2g/24 hrs or > 2 + Dipstick.
Serum creatinine > 1.2mg/dl unless known to be previously elevated
Platelets < 1,00,000/mm3 
Microangiopathic hemolysis
Elevated ALT or AST.
Persistent epigastric pain.
Persistent headache or other cerebral or visual disturbances.
Eclampsia:
Seizures that cannot be attributed to other causes in a woman with preeclampsia.
SUPERIMPOSED PREECLAMPSIA (ON CHRONIC HYPERTENSION)
New onset proteinuria > 300 mg/24hours in hypertensive women but no proteinuria before 20 weeks 
gestation.
A sudden increase in proteinuria or blood pressure or platelet count < 1,00,000/mm3 in women 
with hypertension and proteinuria before 20 weeks gestation.
chronic hypertension
B.P > 140/90mmHg before pregnancy or diagnosed before 20 weeks gestation and persistent after 12 
weeks postpartum.
Preeclampsia is classified in to mild and severe.
Indicators of severity
1. Severe hypertension B.P > 160/110mmHg on two occasions atleast 6hours apart.
2. Proteinuria > 5g/24hours or 3+ or more on two random samples collected atleast 4 hours apart.
3. Elevated serum creatinine level
4. Oliguria < 500ml /24 hours
5. Pulmonary edema
6. Microangiopathic hemolysis
7. Thrombocytopenia (Platelets <100,000/mm3)
8. Elevated ALT and AST
9. Pain in the epigastrium or right upper quadrant.
10. Headache, visual disturbances.
11. Intrauterine growth restriction.
INCIDENCE: 
It occurs in 8 to 10% of pregnancies (Mudaliar and Menon 1972 ; Uphadhyay 1975).
The incidence varies with geographic location. Wide variation in the incidence have been reported 
from different institutions in different countries with widely varying maternal and perinatal 
mortality. Our hospital incidence is 6.5 to 8.5%. 
PREDISPOSING FACTORS: 
AGE : 
Young primigravidas under 20 years are commonly affected. Because of the increased incidence of 
chronic hypertension with advancing age, older women are at greater risk for superimposed 
preeclampsia.
PARITY:
Preeclampsia is primarily a disease of primigravida (70%) and occurs much less frequently in 
subsequent pregnancies (Sibai and colleagues 1995). 
SOCIAL STATUS:
Some investigators concluded that socioeconomically advantaged women have lesser incidence of 
preeclampsia. Lawlor and collegues (2005) did not observe this.
RACE:
  Davies (1970) found that the incidence of preeclampsia was significantly higher in Muslim Arabs and 
Jews born in Iran than in Jews born in North Africa or Isreal. Conde – Agudelo and Belizan (2000), 
Sibai and colleagues (1997), Walker (2000) found increased incidence of preeclampsia in African 
American ethnicity.
GENETIC PREDISPOSITION:
Chesley and Cooper (1986) evidenced that familial and genetic factors have a strong  influence on the 
occurrence of hypertension and proteinuria in pregnancy and are most likely due to Mendelian 
recessive trait.
TWIN PREGNANCY:
Mothers with twin pregnancies have a much higher incidence of preeclampsia compared with singleton 
( Macgillivary 1958, Sibai 2000, Maxwell 2001). 
HYDATIDIFORM MOLE:
Preeclampsia occurs in large rapidly growing mole (Page 1939).
VITAMINS, TRACE ELEMENTS:
Earlier studies showed that women with low dietary calcium were at significantly increased risk for 
preeclampsia. Further studies failed to support this. Chappell and associates (1999) showed that 
treatment with antioxidants vitamin C or E significantly reduced endothelial cell activation and 
preeclampsia
ENVIRONMENTAL FACTORS:
Palmar and associates (1999) reported that living at higher altitude at Colorado increased the incidence 
of preeclampsia. Arterial blood pressure is higher in cold weather probably due to vasoconstriction.
OBESITY:
The incidence of preeclampsia is significantly increased in obese women probably due to an underlying 
tendency to develop essential hypertension.
SMOKING:
Smoking is associated with reduced risk of hypertension during pregnancy. (Zang and colleagues 
1999), (Bainbridge and associates 2005).
Pathogenesis of Pre-eclampsia
Faulty Placentation
Genetic Immunologic or 
Inflammatory factors
Vasoactive agents
Reduced utero placental 
perfusion
Endothelial activation
Endothelial activation
Noxious agents, Cytokines, 
lipids peroxidation
Capillary LeakVasospasm Activation of Coagulation
Hypertension, Oliguria, 
Abruption, Liver ischemia, 
Seizures
Edema, Proteinuria, 
Hemoconcentration
Thrombocytopenia
10
PATHOPHYSIOLOGY:
In normal pregnancies during implantation spiral arterioles undergo extensive 
remodelling as they are invaded by endovascular trophoblasts, replacing the 
endothelium and muscular wall of the vessel with subsequent enlargement of the blood 
vessel (Meekins and coworkers 1994). Madazali and colleagues (2000) showed that in 
preeclampsia there is incomplete trophoblast invasion. This leads to reduced 
uteroplacental perfusion and placental ischemia which causes endothelial dysfunction.
Women with preeclampsia have elevated markers of inflammation. Increased soluble 
fms like tyrosine kinase (sflt-1), soluble endoglin (sEng) and cytokines predispose to 
endothelial dysfunction (Maynard and associates 2003). Sflt-1 antagonises vascular 
endothelial growth factor and placental growth factor by binding them and decreasing 
their unbound serum levels and impairs vascular endothelial growth factor and 
placental growth factor induced vascular relaxation. sEng is a component of TGF-β 
receptor complex and is a hypoxia inducible protein. It is antiangiogenic as it impairs 
TGF-β binding to cell surface receptors. An alteration in the balance of circulating 
factors leads to endothelial dysfunction (Luttum and Carmeliet 2003). Redman and 
colleagues 1999 have proposed that the endothelial cell dysfunction associated with 
preeclampsia can result from a generalized perturbation of the maternal intravascular 
inflammatory adaptation to pregnancy.
INCREASED PRESSOR RESPONSE:
Normally pregnant women develop refractoriness to infused vasopressors ( Abdul 
karim and Assail 1961). Increased vascular reactivity to pressors in women with early 
preeclampsia has been identified by Raab and coworkers 1956 and Talledo and 
associates 1968 using either norepinephrine or angiotensin II and by Dieckmann and 
Michel1937 and Browne1946 using vasopressin. Gant and coworkers 1973 
demonstrated that increased vascular reactivity to angiotensin II clearly preceded onset 
of preeclampsia. 
MECHANISM:
It appears unlikely that the normally blunted pressor response to angiotensin II is due to 
downregulation or decreased affinity of angiotensin II vascular smooth muscle 
receptors (Mackangee and associates 1991).  The metabolic clearance rate of 
angiotensin II is not altered in women with preeclampsia (Magneesand coworkers 
1994). Based on the findings of number of studies it was concluded that the blunted 
pressor response was principally due to decreased vascular responsiveness mediated in 
part by vascular endothelial synthesis of prostaglandins or prostaglandins like 
substances (Cunningham and associates 1975, Gant and coworkers 1974 ).
VASOSPASM :
Atleast two vasoconstrictor mechanism may be operative in preeclamptic women. In 
these women arachidonic acid is converted to thromboxane A2, with an accompanying 
reduction of prostacyclin and prostaglandin E2 in the cyclooxygenase pathway (Cateila 
and associates 1990, Fitzgerald and colleagues 1990, Mitcheil and koeing 1991, 
Tannirandorn and coworkers 1991).
This pathway is responsive to low dose aspirin therapy. The second route is via the 
lipoxygenase pathway which results in an increased platelet production of 15- 
hydroxyecosatetraenoic acid. This inhibits prostacyclin production resulting in further 
vasoconstriction. Biag and coworkers 1990 also reported an increased lipooxygenase 
pathway activation in placentas from hypertensive women.
HEAMODYNAMICS:
The changes and deterioration of function in a number of organs and systems has been 
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identified in severe preeclampsia and eclampsia. Severe preeclampsia and 
eclampsia are accompanied by multiple derangements of cardiovascular system and 
fluid compartments.
During normal pregnancies the maternal blood volume increases markedly. At or near 
term it averages about 40 to 50% above the nonpregnant levels. It starts to increase 
during the first trimester, expands rapidly during the second trimester and then rises at a 
much slower rate during the third trimester to plateau during the last several weeks of 
pregnancy. Increased blood volume results from an increase in plasma and 
erythrocytes. Although more plasma than RBCs is usually added to the maternal 
circulation the increase in volume of circulating erythrocytes averages about 33%.
Pregnancy induced hypervolemia serves to meet the demands of the enlarged uterus 
with its greatly hypertrophied vascular systems, to protect the mother and foetus against 
the deleterious effects of impaired venous return in the erect and supine position and 
very importantly to safeguard the mother against the adverse effects of blood loss 
associated with parturition.
Augmentation of blood volume alters the stroke volume and cardiac output.
Cardiac output during pregnancy is estimated to exceed the output to the nonpregnant 
state by 30 to 50%. It begins to rise around the fifth week and peaks between the 
middle of second and third trimesters. Cardiac output is maintained at the same level 
thereafter. Changes in body position can induce substantial changes in cardiac output, 
its level rising in the lateral position and declining in supine position. The early 
increase in cardiac output can be attributed to augmented stroke volume that results 
from decreased peripheral vascular resistance. Later in pregnancy resting pulse 
increases and stroke volume increases even more, presumably because of increased 
diastolic filling from the expanded blood volume. 
Heart rate also increases peaking during the third trimester. The average is about 10 to 
15 beats/minute (Stein and coworkers 1999 ). Systemic arterial pressure begins to fall 
during the first trimester reaches a nadir in midpregnancy and returns to prepregnancy 
level before term. As the fall in diastolic pressure is greater than the fall in systolic 
pressure, pulse pressure widens. During normal pregnancy the total peripheral 
resistance decreases by 25%. Blood pressure is a product of cardiac output and total 
peripheral resistance. Hence the reduction in blood pressure results from a decline in 
total peripheral resistance which decreases due to vasodilatation, probably mediated by 
gestational hormonal activity increased levels of circulating prostaglandins, increased 
heat production by the developing foetus and the creation of low resistance circulation 
in the pregnant uterus.
Duwekot and colleagues 1993 showed that the left ventricular size is increased in 
normal pregnancies as a result of eccentric enlargement that increases radius to wall 
thickness and thus end diastolic dimensions. Markedly  attenuated afterload manifested 
by diminished vascular resistance and mean arterial pressure allows the appreciable 
increase in cardiac output. Because changes in stroke volume are directly proportional 
to end diastolic volume, the implication is that the inotropic state of the myocardium 
changes little during normal pregnancy (Katz andcoworkers 1978). The sustained 
cardiac changes during pregnancy are similar to acute changes reported for moderate to 
strenuous exercise. 
An important study by Clark and colleagues 1989 contributed greatly to the 
understanding of cardiovascular physiology during pregnancy. Using invasive 
haemodynamic studies they showed that late pregnancy was associated with increases 
in heart rate, stroke volume and cardiac output. Systemic vascular and pulmonary 
vascular resistances both decrease significantly, as did colloid osmotic pressure. There 
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was no change in intrinsic left ventricular contractility. Pregnancy is 
characterized by normal left ventricular function and not hyperdynamic function as 
once thought. These investigators concluded that maintenance of normal left ventricular 
filling pressures comes about as the result of ventricular dilatation. 
HAEMODYNAMIC ALTERATIONS IN PREECLAMPSIA;
 In preeclampsia there are alterations in the physiological changes in the 
haemodynamics. It is known that increase in intravascular volume that occurs in normal 
pregnancy is diminished or completely absent in patients with preeclampsia. This may 
be due  to generalised vasoconstriction made worse by increased vascular permeability. 
Haemodynamic values obtained in women with  preeclampsia using invasive 
cardiovascular monitoring by various investigators showed variables that define 
cardiovascular status range from high cardiac output with low vascular resistance to 
low cardiac output with high vascular resistance. Similarly left ventricular filling 
pressures estimated by pulmonary capillary wedge pressure determination range from 
low to pathologically high. Atleast three factors may explain these differences. 1) 
Women with preeclampsia might present with spectrum of cardiovascular findings 
dependent of severity and duration. 2) chronic underlying disease may modify the 
clinical presentation or 3) therapeutic interventions may significantly alter these 
findings. It is likely that more than one of these is operative. 
Haemodynamic status of women with preeclampsia prior to active treatment has also 
been studied by Cotton and associates 1964. They identified normal left ventricular 
filling pressures, high systemic vascular resistance and hyperdynamic ventricular 
function. Beneditti 1980, Hankins 1984 and their associates reported that women with 
severe preeclampsia who were being treated with magnesium sulphate and hydralazine 
plus aggressive intravenous fluid therapy for volume expansion had the lowest systemic 
vascular resistances and highest cardiac output. These women had filling pressures that 
exceeded normal but their ventricular function remained hyperdynamic because of 
increased cardiac output. Cotton and coworkers 1988 reported findings from 45 women 
with severe preeclampsia  or eclampsia and described high systemic vascular résistance 
and hyperdynamic ventricular function in most of the patients. 
LEFT VENTRICULAR (LV) MECHANICS IN PREECLAMPSIA: 
Increased systemic vascular resistance and contracted blood volume are 
characteristic findings in preeclampsia. These alterations in cardiovascular 
hemodynamics can adversely affect ejection phase indices of left ventricular 
performance making it difficult to separate abnormalities resulting from changes in 
load from those caused by depressed myocardial contractility. To address this issue 
the contractility-sensitive, load-independent relationship between left ventricular 
end-systolic wall stress and rate-corrected velocity of fiber shortening was assessed 
in 10 nulliparous patients with preeclampsia. Comparisons were made with data 
obtained from 10 age-matched normotensive women with uncomplicated 
pregnancies (control subjects). Studies were performed by means of two-
dimensionally targeted M-mode echocardiography and calibrated carotid pulse 
tracings during early labor, 1 day after delivery, and 4 weeks after delivery. During 
early labor and 1 day after delivery, patients with preeclampsia had elevated blood 
pressure and increased total systemic resistance. These parameters returned to 
normal by 4 weeks after delivery. Before delivery and 24 hours after delivery, the 
patients with preeclampsia had lower overall left ventricular performance (as 
measured by cardiac output and rate-corrected velocity of fiber shortening) and 
higher left ventricular afterload (as measured by left ventricular end-systolic wall 
stress) when compared with control subjects. These differences were no longer 
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present 4 weeks after delivery. Despite the time-related intergroup 
differences in hemodynamics, left ventricular contractility was similar between 
normotensive and preeclamptic subjects at all stages of the study. Thus when load is 
eliminated as a confounding variable, the decrements in overall left ventricular 
performance measured in patients with preeclampsia reflect a mechanically 
appropriate response to increased afterload  rather than an abnormality in the 
ventricular contractile state. (Rafik Hamad et al  Am Heat J. 1991 Jun; 121)
In pregnancies complicated by preeclampsia, especially early-onset preeclampsia, the 
diastolic LV function is impaired and levels of biomarkers, NT-pro-BNP and cystatin C, 
are increased in comparison to normal pregnancy.
Cardiac natriuretic peptides include atrial natriuretic peptide ( ANP) and B- natriuretic 
peptide ( BNP) which are secreted by cardiomyocytes in response to stretch of atrial 
wall due to volume overload. They are vasoactive and promote sodium and water 
excretion. Lowe and coworkers ( 1992 ) showed that plasma levels of ANP during 
normal pregnancy are maintained in the nonpregnant range despite the increase in 
plasma volume. This physiological adaptation may be important in allowing the 
expansion of extracellular fluid volume in normal pregnancy. Borghi and colleagues 
(2000), Gallery and Lindheimer (1999) showed that secretion of ANP is increased in 
preeclampsia. 
Recently BNP has been evaluated as a marker for left ventricular function (Heidenrich 
and associates 2004). In normal pregnancy median BNP values are less than 20 pg/ml 
and stable throughout gestation. In severe preeclampsia BNP levels elevated. This may 
reflect ventricular stress or subclinical cardiac dysfunction associated with 
preeclampsia.
Pulmonary edema occurs in 3% of preeclamptic patients and is a significance cause of 
maternal morbidity and mortality. Sibai et al 1987 found an incidence of 2.9% in 
preeclampsia. Pulmonary edema may occur due to left ventricular dysfunction 
secondary to high systemic vascular résistance , volume overload in the phase of 
contracted intravascular space, decreased plasma colloid oncotic pressure or pulmonary 
capillary membrane injury. 
Diastolic dysfunction refers to an abnormality in the heart’s filling during diastole. It is 
characterised by elevated diastolic pressure in the left ventricle despite normal or 
subnormal diastolic volume. Any condition or process that leads to impaired relaxation 
of left ventricle can lead to diastolic dysfunction. In preeclampsia due to increase in 
total peripheral resistance there is increase in afterload which causes the left ventricle to 
become stiff leading to diastolic dysfunction. When the left ventricle cannot be 
normally filled blood regurgitates into left atrium and in backward direction into the 
lungs leading to pulmonary edema. 
There are four echocardiographic patterns of diastolic dysfunction grade 1 to 4. The 
mildest form is called an abnormal relaxation pattern or grade 1 diastolic dysfunction 
and patients will not have clinical signs and symptoms of heart failure whereas grade 2 
to grade 4 patients are symptomatic. The subclinical diastolic dysfunction with normal 
systolic function of left ventricle in preeclamptic patients can be detected by 
echocardiography which cannot be detected by routine history, physical examination 
and investigations like chest X- ray and ECG. 
ECHOCARDIOGRAPHY: 
 Using 2D and 2D derived M-mode echocardiography quantitative measurements of 
cardiac dimensions, area and volume are derived.
Doppler echocardiography measures blood flow velocities in the heart.
Echocardiography allows assessment of cardiac function by parameters like a) end 
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diastolic pressure and chamber volume.
b) end systolic pressure , ejection pressure and fractional shortening and 
c) Cardiac output.
Echocardiography is the simple and accurate noninvasive method to assess cardiac 
function during pregnancy. It uses ultrasound to create real time images of the 
cardiovascular system in action. 
2D, M- mode, Doppler echo: 
Ejection fraction is a simple measure of how much of end-diastolic volume is ejected or 
pumped out of the LV with each contraction. Quantitatively left ventricular ejection 
fraction (LVEF) can be calculated from M-mode, 2D and  3D echocardiogram.
Fractional shortening (FS) is the percent change in LV cavity dimension with each LV 
contraction and is calculated from the following equation.
FS  = LVED – LVES
         -------------------     × 100%
                 LVED
Where LVED is the LV end diastolic dimension and LVES is the LV end systolic 
dimension. The thickness of the ventricular posterior wall and that of ventricular 
septum are measured from the same M- mode echocardiogram. These values are used 
to calculate LV mass thereby detecting LV hypertrophy.
The most important cardiac complications like pulmonary edema and congestive heart 
failure can occur in the presence of an entirely normal LV systolic function. So the 
noninvasive evaluation of left ventricular diastolic function has become increasingly 
important.
In contrary to the popular belief diastole is an active metabolic process during which 
myocardium relaxes. The process of myocardial relaxation is as important as 
myocardial contraction. There is phasic blood flow to the ventricle during diastole i.e. 
early rapid ventricular filling followed by late diastolic filling by atrial contraction. 
Alterations in this phasic blood flow pattern reflect diastolic dysfunction. These 
diastolic inflow patterns can be assessed accurately by pulse Doppler echocardiography 
and colour flow imaging. They are expressed as E- early rapid filling velocity , A – late 
filling velocity by atrial contraction in milliseconds. The normal E/A ratio being 0.8 to 
2.
Diastole begins with myocardial relaxation at the end of systolic contraction. During 
diastole the left ventricle must receive an adequate volume while maintaining low 
intracavitary pressure throughout a wide range of heart rate and loading condition. 
To accomplish this  the ventricle relaxes during early diastole and the walls distend 
readily allowing the chamber to receive a wide range of inflow volumes at low 
filling pressures. To ensure optimal diastolic filling at rest and during exercise the 
left atrium contracts before ventricular activation, providing an additional boost to 
ventricular filling. During sinus rhythm the mitral inflow velocity displays a 
biphasic morphology consisting of an early peak (E) followed by a deceleration 
phase and by a second peak during  atrial contraction(A).
Another valuable index in assessment of left ventricular diastolic function is 
isovolumetric relaxation time (IVRT). IVRT is the short period of early diastole during 
which ventricular volume remains constant and the pressure falls. It is the time between 
the closure of aortic valve and opening of mitral valve. The normal value being 73 to 
110 ms. The value of more than 110ms is considered as prolonged IVRT reflecting LV 
diastolic dysfunction.
Diastolic filling pattern is characterized further by measuring the deceleration time, 
(DT). DT is the interval from the peak of the E velocity to its extrapolation to baseline. 
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In patients with a relaxation abnormality as the predominant diastolic 
dysfunction , DT is prolonged because with a slower and continouos decrease in LV 
pressure until mid to late diastole, it takes longer for LA and LV pressures to 
equilibrate.
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AIM
To determine the left ventricular dysfunction in preeclamptic women by measuring 
the left ventricular systolic and diastolic indices using echocardiography.
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SUBJECTS AND METHODS
Patients with preeclampsia who had been admitted in the antenatal ward of 
Government RSRM lying in hospital for women over the period of one year from 2008 
September to 2009 September were the subjects of the study.
Among them 54 patients who fulfill the study criteria were selected and they 
constituted group 1 of the study.
INCLUSION CRITERIA
1. Patients with mild Preeclampsia which was diagnosed when there is a sustained 
systolic blood pressure of 140 mm Hg or more, and or a diastolic blood 
pressure of 90mm Hg or more present on two or more occasions atleast six 
hours apart occurring after 20th week of gestation associated with a proteinuria 
of > 0.3gm protein in a 24 hours urine sample or > 30 mg/dl or   > 1+ on 
dipstick in a random urine sample. 
2. Patients with severe Preeclampsia which was diagnosed when blood pressure 
was > 160/110 mmHg or proteinuria of > 5gm/24 hours or 2+ or more.
3. Age 18 to 35 years 
4. Gestational age 28 to 36 weeks.
5. The known period of hypertension averaged 20 days.
EXCLUSION CRITERIA:
1. Patients with preexisting hypertension or 
2. Patients with known cardiorespiratory disease
3. Patients with anaemia
4. Patients with gestational diabetes mellitus 
5. Patients in labour.
Out of 54 patients studied 24 patients fulfilled the criteria for severe preeclampsia, 30 
patients fulfilled the criteria for mild preeclampsia.
All the patients were put on antihypertensive drugs. All the cases of mild Preeclampsia 
were put only on tablet alpha methyldopa 250mg 8th hourly. The severe cases of 
preeclampsia were put on tablet alpha methyldopa 250mg 8th hourly and tablet 
nifedipine 10mg 8th hourly.
None of the patients were studied during labour.
CONTROL GROUP 2
50 normal normotensive pregnant patients selected at random who come to the OPD of 
our institute at the same period constituted group 2. Their gestational age ranged from 
28 to 36 weeks. Their age ranged from 18 to 35 years. Mean age 24 years. 
CONTROL GROUP 3
50 normal nonpregnant patients selected at random who come to the OPD of our 
institute at the same period who were from 18 to 35 years of age constituted group 3. 
Mean age is 26 years.
Group 1 Group 2 Group 3
Pre Eclamptic Women Normotensive Pregnant women Normal non - pregnant 
women
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Group 1
Age No of Patients Percentage
18-20 17 31.48
21-25 22 40.74
26-30 10 18.57
31-35 5 9.25
Mean Age - 23 years
Group 2
Age No of Patients Percentage
18-20 14 28
21-25 19 38
26-30 13 26
31-35 4 8
Mean age - 24 years
Group 3
Age No of Patients Percentage
18-20 7 14
19
21-25 16 32
26-30 14 28
31-35 13 26
Mean age - 26 years
Parity
Group Nulliparous Multiparous
1 28 26
2 15 35
3 10 40
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 MEAN BLOOD PRESSURE OF THREE GROUPS
Group Systolic Diastolic
Group -1 154 98
Group - 2 114 71
Group - 3 119 79
ECHOCARDIOGRAPHIC STUDIES:
All patients were examined by a cardiologist using Aloka echo machine with 2.5mHz 
transducer at the Department of Cardiology Stanley Medical College Hospital. 
Echocardiography of left ventricle was obtained under standard conditions during quiet 
expiration with patients in the left lateral recumbent positions after the patients 
remained undisturbed in this position for 15 minutes.
MEASUREMENTS:
 M-mode, 2D and Doppler echocardiographic evaluation were performed in all patients 
in the standard left parasternal axis view with continuous ECG gating according to the 
ASE guidelines. LV dimensions like EF, ESD and EDD are measured by 2D and M-
mode. Interventricular septum and posterior wall diameter are also measured in M-
mode. Using pulse doppler echocardiography mitral inflow velocities IVRT and DT are 
measured.
Parameters used to measure systolic functions are 
EF = EDV – ESV  
-------------- ×  100
     EDV
Normal 50 to 75%.
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FS  = LVED – LVES
-------------------- × 100%
       LVED
Normal 25 to 46%. 
EDV- end diastolic volume.
ESV- end systolic volume.
LVED – left ventricular end diastolic dimension.
LVES - left ventricular end systolic dimension.
Parameters used to measure diastolic function 
E/A ratio: early filling / filling due to atrial contraction.
Normal 0.8 to 2.
Isovolumetric Relaxation Time (IVRT):  Time interval between closure of aortic 
valve and opening of mitral valve. Normal 73 to 110ms. More than 110ms is considered 
as prolonged IVRT indicative of diastolic dysfunction.
Deceleration time: (DT)
Time taken for left atrial and left ventricular pressures to equilibrate.
Normal 160 to 230 ms. Prolonged in diastolic dysfunction. 
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RESULTS 
The individual values of end diastolic dimensions, end systolic dimensions, EF, FS and 
mitral inflow velocities E,A are depicted in the graph.
The mean left ventricular end diastolic dimensions in group 1,2 and  3 were 4.81, 4.84 
and 4.55 cms respectively. The mean end systolic dimensions of group 1,2 and 3 were 
3.33, 3.30 and 3.06 respectively. There were no significant differences in the mean end 
diastolic and end systolic dimensions between preeclamptic and normotensive pregnant 
women, although the mean enddiastolic and end systolic dimensions in the two groups 
of pregnant women were significantly greater than in the nonpregnant group.
The mean EF in the three groups were 60%, 58.3% and 58.8% respectively. They were 
comparable and there is no statistical significance. 4 patients in group one showed EF < 
50% that defines left ventricular systolic dysfunction.
Mean FS in the three groups were 30.3%, 31.6% and 32.6% respectively. Only 4 
patients in group 1 showed FS < 25% that defines left ventricular systolic dysfunction.
MITRAL INFLOW VELOCITIES:
The mean E/A ratio in the three groups were 1.03, 1.23 and 1.24 respectively. 17 
patients in group 1 had E/A ratio <1 indicative of diastolic dysfunction. Mean IVRT in 
the three groups were 108, 90 and 89 respectively. The mean DT in three groups were 
209, 188 and 189 respectively . The same 17 patients who showed reversed E/A ratio 
also had prolonged IVRT and DT confirming the diagnosis of diastolic dysfunction.
STATISTICAL ANALAYSIS:
LV systolic and diastolic function indices were compared among the three groups using 
Tukey-HSD test with significance level .050. There was a statistically significant LV 
diastolic dysfnction in the preeclamptic group. P value <0.001.
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Group 1 Group 2 Group 3 Statistical Analysis
Pre-eclamptic Pregnant 
Women
Normotensive pregnant 
women
Non Pregnant 
women P Value
Mean SD Mean SD Mean SD I Vs 2 1 Vs 3 2 Vs 3
End disastolic dimension 
(cm)
4.81 0.5 4.84 0.44 4.55 0.28 NS <0.001 <0.001
End systolic dimension 
(cm)
3.33 0.35 3.30 0.33 3.06 0.24 NS <0.001 <0.001
FS 30.33 7.65 31.66 5.09 32.69 4.63 NS NS NS
EF 60.24 4.18 58.38 4.75 58.80 3.26 NS NS NS
Mitral inflowvelocity E/A 1.04 0.20 1.23 0.09 1.24 0.08 <0.001 <0.001 NS
IVRT (msec) 108.76 15.76 90 10.54 89 10.71 <0.001 <0.001 NS
DT (msec) 209.35 31.38 188.94 20.78 189.80 22.99 <0.001 <0.001 NS
STATISTICAL ANALYSIS
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Range OF LV SYSTOLIC AND DIASTOLIC INDICES
Group - I Group - II Group - III
EDD 3.12  –  5.50 3.12  –  5.35 3.9  –  5
ESD 2.20  –  4.20 2.90  –  4 2.6  –  3.95
EF 51  –  67 50  –  65 50  –  65
FS 25  –  47.62 25  –  43.21 26.67  –  38.72
E/A 0.7  –  1.32 1.07  –  1.68 1.14  –  1.53
IVRT 86  –  136 73  –  106 76  –  110
DT 160  –  260 160  –  230 160  –  230
Group 1 Group 2 Group 3
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DISCUSSION 
The performance of left ventricle depends upon factors like 
1. Preload (LV end diastolic volume or pressure)
2. Contractility (inotropic state)
3. Afterload (the résistance against which the LV has to contract).
 In normal pregnancies there is marked increase in the blood volume that lead to 
significant volume overload of the heart. In preeclampsia there is an alteration in this 
haemodynamic pattern. Whether these haemodynamic changes influence the left 
ventricular function in preeclampsia remain unclear. In this study we attempted to 
address this question. J.Kuzniar et al 1983 in their study by echocardiography found 
that the mean end diastolic dimension and mean end systolic dimension were 
significantly elevated in pregnant patients above the mean of nonpregnant patients. In 
this respect, our data is comparable with the former study, though there is no significant 
difference of values between the preeclamptic and normotensive pregnant group. This 
may be due to very mild changes in the blood volume between the two groups (Silver 
and Seeback 1996).
The left ventricular performance during normal pregnancy was studied by Rubler and 
colleagues, Katz and associates using echocardiography. They did not find significant 
differences in percentage of FS between the subjects in the control group and those who 
are pregnant at term. J.kuzniar  et al reported that left ventricular function as expressed 
by echocardiographic ejection phase indices did not differ substantially between the 
non pregnant patients and normal pregnant patients in the third trimester. In our study, 
the indices of left ventricular function were consistent with the above study showing no 
significant difference between the subjects in the control group and the normotensive 
pregnant group. 
The findings of earlier studies on left ventricular contractile functions in hypertensive 
pregnant patients vary. Lim and Walters showed a diminished left ventricular 
performance evidenced by systolic time intervals using echocardiography.
Larkin and coworkers did not find significant differences in the functional status of the 
left ventricle, as evidenced by echocardiographically derived EF between normotensive 
and hypertensive pregnant patients. On the other hand Beneditti and coworkers, 
Rafferty and Bercowits using flow directed pulmonary artery catheter for the study of 
severe preeclampsia found a hyperdynamic left ventricular function in terms of the 
relationship between the stroke work index and pulmonary capillary wedge pressure.
J Kuzniar et al reported that the left ventricular systolic function was well preserved in 
most of the preeclamptic women. Only 7% of them showed depressed left ventricular 
performance as evidenced by percentage fractional shortening.
In our study it is found that in most of the preeclampsia patients the indices of left 
ventricular systolic function fell within normal range. These observations indicate good 
cardiac contractile function. Even though the left ventricle operate on the ascending 
limb of the left ventricular function curve only 4 out of 54 patients of this group had 
depressed LV systolic function. These findings correlate well with the J Kuzniar et al 
study.
The mechanism of this LV systolic dysfunction may be related to high afterload. None 
of the above studies addressed the issue of diastolic dysfunction.
Diastolic dysfunction is a well described clinical entity in essential hypertension 
especially in patients with left ventricular hypertrophy as the hypertensive heart has 
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less relaxing capacity. Williams C madie et al found that among the 25 
preeclamptic women who developed pulmonary edema during antepartum and 
postpartum period, 12 (48%) showed diastolic dysfunction as evidenced by reversed 
E/A ratio with normal LV systolic function.
Desai DK et al reported that among the 16 preeclamptic patients who developed 
pulmonary edema in the antenatal period 12 (75%) patients showed LV diastolic filling 
abnormalities in significant proportion with preserved systolic function compared to 
control normotensive group.LV diastolic dysfunction as evidenced by reversed E/A 
ratio and prolonged IVRT and DT occurred in 17/54 (30%) of our preeclampsia 
patients. In our study it is interesting to note that only 2 out of 17 patients had LV 
hypertrophy.
Due to increased TPR in preeclampsia there is an increase in afterload and the left 
ventricle becomes stiff. This may be the possible mechanism by which diastolic 
dysfunction develops independent of LV hypertrophy.
Pulmonary edema occurs when the forces favouring fluid retention within the 
pulmonary intravascular space (Plasma oncotic pressure and interstitial hydrostatic 
pressure) are overwhelmed by those driving fluid from intravascular to the interstitial 
space (pulmonary capillary hydrostatic pressure and interstitial oncotic pressure). 
Accordingly decrease in the plasma oncotic pressure by relative (dilutional) or absolute 
reduction of plasma colloid by transfer of plasma colloid to the interstitial space 
(capillary leak) or increase in capillary hydrostatic pressure (volume expansion or 
cardiac dysfunction) is frequently the cause, singly or in combination. All these factors 
have been implicated in the genesis of pulmonary edema associated with pregnancy.
Heart failure and pulmonary edema due to primary cardiac disease have traditionally 
been thought to be mediated by impaired left ventricular systolic function. Reduced 
systolic function results in incomplete left ventricular emptying, elevated left 
ventricular diastolic pressure and ultimately increased pulmonary capillary hydrostatic 
pressure. However recent evidence has indicated that over one third of cardiogenic 
pulmonary edema is due to abnormal left ventricular diastolic filling with normal or 
even hyperdynamic systolic function. In these cases increases in residual left atrial 
volume raise the left atrial pressure which is inturn transmitted to the pulmonary 
capillary bed. Impaired filling may be due to impaired ventricular filling in early 
diastole, reduced myocardial compliance (the stiff heart syndrome) or combination of 
the two.
Patients with heart failure due to impaired left ventricular contractile function have a 
relatively poor prognosis. When ventricular filling is impaired, relatively small 
increments in intravascular volumes translate into relatively large increases in left 
ventricular end diastolic and pulmonary capillary hydrostatic pressure. This state of 
affairs make these patients extraordinarily sensitive to volume loading and changes in 
capillary permeability. 
MANAGEMENT OF HYPERTENSION IN PREECLAMPTIC PATIENTS
All these patients in group1 were put on antihypertensive drugs like alpha methyldopa 
and nifedipine. All the cases of mild preeclampsia were put only on alpha methyldopa 
250mg eight hourly and advised atleast 8 hours of sleep in the night and 2 hours of rest 
in the afternoon in left lateral position. With this treatment blood pressure has been 
controlled to systolic pressure ranging 110 to 120 and diastolic pressure ranging from 
70 to 84 mmHg. In severe preeclampsia group all patients were on tab methyldopa 
250mg 8th hourly and cap nifedipine 10ms 8th hourly. One patient showed uncontrolled 
blood pressure and it was fluctuating. Blood pressures of other patients were reduced 
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from severe to mild degree. Their proteinuria also showed improvement from 
3+ to 1+. 
PERIPARTUM  MANAGEMENT  OF  PATIENTS  WITH  LV 
DYSFUNCTION:  
Among the 17 patients with LV dysfunction 10 patients had mild preeclampsia and 7 
patients had severe preeclampisa. Since the development of pulmonary edema and 
cardiac failure are more common during labour and immediate postpartum, careful 
monitoring and appropriate management of these patients is crucial. Among the 10 
mild preeclamptic patients with LV dysfunction 6 patients had normal vaginal 
deliveries. 4 patients went in for LSCS, 2 indicated by previous LSCS and 2 for fetal 
distress.
Among the 7 patients with severe preeclampsia 4 patients had normal vaginal deliveres. 
1 patient developed imminent eclampsia and was started on magnesium sulphate 
regimen and her pregnancy was terminated by cerviprime induction. She expelled a 
dead born fetus weighing 650gms. Other 2 patients had LSCS one for fetal distress and 
the other indicated by breech presentation.
All these patients were admitted in Intensive Care Unit (ICU) during labour. Sedation 
was given with Injection Diazepam 10mg to alleviate pain, anxiety which may lead to 
tachycardia. They were kept in propped up position. Pulse rate, temperature and 
respiratory rate were recorded ½ hourly. B.P. and unrine output recorded hourly. Spo2 
was monitered with pulse oximeter, and oxygen by mask was administered at the rate 
of 4-6 litres/min, when Spo2 falls below 90%. Frequent auscultation of lung bases was 
done. IV fluids when used was maintained at the rate of 75-100ml/hour so as to 
maintain an adequate urine output of 1ml/kg/hour.
Jugular Venous Pressure (JVP) was measured 4th hourly to detect fluid overload. Ideally 
patients with Lvdysfunciton should be monitored with Central Venous Pressure (CVP) 
to detect changes in Pulmonary Capillary Wedge Pressure (PCWP). In the absence of 
invasive hemodynamic monitoring JVP can be used. Normal right atrial pressure is 0 to 
5 mm Hg which equals CVP thereby indicating PCWP. Since JVP reflects changes in 
right atrial pressure it can be used in the absence of invasive hemodynamic monitoring. 
Normal JVP is up to 3 cms measured from the Angle of Louis. Every 1 cms increase in 
JVP is equal to 0.68mmHg increase in CVP. Even 1 cms increase in JVP indicates 
significant volume overload. Injection Frusemide 40mg i.v is given when there is fluid 
overload as indicated by elevated JVP and basal lung crepitations.
Two patients with severe preeclampsia had severe uncontrolled B.P. during labour and 
nitroglycerine drip was started at the rate of 2.5 µ g/kg body weight and dosage titrated 
to maintain systolic B.P around 120-130 mmHg and diastolic B.P around 80-90mmHg. 
Infusion was stopped when systolic B.P was <100mmHg. Since Nitorglycerine is a 
venodilator it reduces preload thereby preventing pulmonary edema. One patient with 
severe preeclampsia had uncontrolled B.P with tachycardia, during labour. She was 
treated with i.v. labetolol starting with a 20mg bolus i.v and if not effective within 10 
minutes followed by 40mg then 80mg every 10minutes but not to exceed total dose of 
220mg.
For mild preeclamptic patients tablet alphamethyl dopa 250mg 8th hourly was continued 
and their B.P. was under control. Since tachycardia reduces the diastolic filling time 
and precipitates pulmonary edema, the control of heart rate has a key role in the 
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management of patients with LV dysfunction. 
For patients who underwent LSCS, the mode of anaesthesia was discussed with 
anaesthetist. Since GA may cause sudden hypertension and tachycardia due to 
sympathetic stimulation caused by tracheal intubation, regional anaesthesia was used in 
preference; These patients were monitored in ICU for 72 hours postpartum, and then 
transferred to high risk postnatal ward.
None of the 17 patients developed complications like pulmonary edema or cardiac 
failure. Their B.P returned to normal within 15 days postpartum.
FOETAL OUTCOME:  
Among the 53 patients who had live child, 28 were female children and 25 were male 
children. The average weight of the babies was 2.6 kg and the finding of LV diastolic 
dysfunction was found to have no corrletation with foetal outcome. 
FOLLOW UP:
Out of the 17 patients who showed diastolic dysfunction, 2 patients were lost for 
follow up. 15 patients were followed up with echocardiography after a mean period 
of 28 days. They were found to have normal diastolic function. 
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Characteristic of the patients who showed LV diastolic dysfunction
S.No Name/ IP No
Clinical Data Systolic  Function Diastolic Function
Parity Mode of  Delivery
Fetal  
Weight  
(kg)Age BP U/A EF FS E/A ratio
IVRT 
msec
DT 
msec
1. Bhuvaneshwari/1333 21 170/110 3+ 56 27.22 0.9 135 243 Multi para Lab. Nat 2.7
2. Jabin/ 11413 21 180/110 3+ 52 47.62 0.8 127 245 Primi para DeadBorn 0.65
3. Tamilselvi/13079 25 150/100 1+ 54 24.37 0.7 136 248 Multi para Lab. Nat 2.5
4. Jayalakshmi/6247 18 150/100 1+ 57 31.19 0.8 135 250 Primi para Lab. Nat 2.4
5. Mohana.6397 26 140/90 Trace 60 37.25 0.7 128 246 Primi para Lab. Nat 2.9
6. Poongodi/6705 18 180/110 3+ 53 38.46 0.8 125 241 Multi para LSCS 3
7. Alamelu/10140 35 160/110 2+ 62 25.50 0.9 124 244 Primi para Lab. Nat 2.2
8. Vidhya/10286 19 160/110 3+ 56 39.22 0.8 12 239 Multi para LSCS 2.5
9. Roshini / 10521 35 160/110 2+ 51 26.37 0.8 120 244 Primi para Lab. Nat 2.6
10. Aysha/ 10571 28 150/100 1+ 55 30.14 0.7 135 242 Primi para Lab. Nat 2.4
11. Nadiya/ 10680 22 140/90 1+ 0 33.33 0.8 123 238 Primi para LSCS 3
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S.No Name/ IP No
Clinical Data Systolic  Function Diastolic Function
Parity Mode of  Delivery
Fetal  
Weight  
(kg)Age BP U/A EF FS E/A ratio
IVRT 
msec
DT 
msec
12. Nirmala/ 10723 20 150/100 1+ 60 32.17 0.9 134 250 Primi para Lab. Nat 2.1
13. Guna / 10721 26 150/100 1+ 58 32 0.8 140 260 Multipara LSCS 3.4
14. Mahalakshmi/ 10922 20 170/110 3+ 65 36.36 0.7 120 258 Primipara Lab. Nat 2.5
15. Chitra/ 11139 25 150/100 1+ 23 32.28 0.8 135 234 Multi para Lab. Nat 3
16. Maheswari/ 11121 20 150/90 1+ 64 31.25 0.8 132 245 Multi para LSCS 3.1
17. Pasupathy. 11356 18 140/100 1+ 55 25 0.7 130 240 Multi para LSCS 2.5
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CONCLUSION 
It was observed that 
1. LV systolic function was within normal limits in most of the 
preeclamptic patients 
2. Statistically insignificant number of patients 4/54 (7.4%) had LV 
systolic dysfunction p value > 0.05.
3. Statistically significant LV diastolic dysfunction was seen in 17/54 
(31.48%) of preeclamptic patients p < 0.001.
4. LV hypertrophy was a rare finding occurring only in two patients of the 
study group.
5. Appropriate management of the patients who showed LV dysfunction 
prevented pulmonary edema and cardiac failure. 
CLINICAL IMPLICATIONS:
While overt cardiac failure associated with preeclampsia is rare subclinical LV 
dysfunction is being increasingly recongnised as in this study. Abnormal diastolic 
function is the most common cause of heart failure in patients with normal LV systolic 
function. This can be easily diagnosed by echocardiography with evidence of abnormal 
relaxation, increased filling pressure and decreased compliance as well as normal LV 
dimensions and preserved LV ejection fraction.
Inspite of having high afterload, the systolic function is well preserved in preeclampsia. 
But in contrary diastolic dysfunction was observed in significant number which is a 
predisposing factor for pulmonary edema. Even in asymptomatic patients the presence 
of diastolic dysfunction portend poor clinical outcome. Maintaining normal diastolic 
function may be the key to cardiac immortality. In the normal population with normal 
diastolic function, filling pressures increases slightly with exercise. It seems that 
diastolic dysfunction leads to development of exercise induced high filling pressures. In 
these patients cardiac output is increased at the expense of increased filling pressures. 
The sustained cardiac changes during pregnancy are similar to acute changes reported 
for moderate to strenuous exercise. Preeclamptic patients with grade 1 diastolic 
dysfucntion are asymptomatic as long as the diastolic filling period is sufficiently long 
to accommodate the delay in myocardial relaxation. The key to management is the 
prevention of tachycardia and the control of factors that further aggravates diastolic 
dysfunction which include management of hypertension, control of obesity, 
management of diabetes mellitus if associated. During labour betablocker therapy is 
helpful in minimising tachycardia.
It is to be expected that the additional stress caused by labour uncontrolled fluid 
therapy or general anaesthesia may be potentially dangerous in these patients with 
subclinical left ventricular dysfunction. It may also be of interest to know that left 
ventricular dysfunction associated with preeclampsia is reversible. These may shed 
light on the pathogenesis of peripartum cardiomyopathy. There is also a link between 
preeclampsia and future cardiovascular disease.(Journal of Clinical Endocrinology and 
Metabolism vol89;2004). Women with a history of preeclampsia demonstrate altered 
expression of angiogenesis related proteins and increased insulin resistance more than 
one year post partum. These factors may contribute to their risk of future cardiovascular 
disease. Further studies are required addressing this issue.
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PROFORMA
NAME : AGE : IPNO : DOA:
SOCIAL STATUS OBSTETRIC HISTORY : LMP: EDD:
PAST HISTORY :
FAMILY HISTORY :
PHYSICAL EXAMINATION – Wt :  kg BUILD : NUTRITION :  
ANAEMIA
EDEMA LEGS : PULSE:    /mt,  BP:    mmHg, JVP:       CVS: RS
OBSTERIC EXAMINATION:
P/A:
P/V:
INVESTIGATION: URINE-ALBMIN SUGAR- DEPOSIT –
HB- gm/dl,  BLOOD SUGAR - mg/dl, BLOOD UREA - mg/dl
SERUM CREATNINE - mg/dl SERUM URIC ACID -mg/dl
BT - , CT- PLATELET COUNT -
LFT:
FUNDUS EXAMINATION:
TREATMENT :
MANAGEMENT DURING LABOUR
MODE OF LABOUR: APGAR OF BABY :
POSTNATAL PERIOD :
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ECHOCARDIOGRAPHIC DATA
M-mode :
AORTA: cm, LA : cm,
LV-ESD : cm, LVEDD : cm        EF : %
LVPW : cm, IVS : cm, FS:
2D & DOPPLER:
MV: AV: PV: TV:
Evel - A vel E/A: DT:  ms,    IVRT: ms
OTHER DEFECTS:
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